DelveInsight's Dry Eye Disease Market Insights report includes a comprehensive understanding of current treatment practices, ...

The global fungal keratitis treatment market is on a robust growth trajectory, with projections indicating a rise from USD ...

then watch any of the streams in the Marvel Rivals category with Drops enabled. Once you've watched long enough to earn one of the cosmetics, access your Twitch Drop Inventory page, claim your ...

Considering that they’re located on a campus loaded with spend-happy students, businesses in Dinkytown and Stadium Village should be sure things. As the closed-down Gray’s Campus Drug store in ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

Bryan Johnson, the 47-year-old tech entrepreneur known for his extensive anti-aging efforts, has stopped using Rapamycin, a drug traditionally used as an immunosuppressant but taken off-label by some ...

He threatens to flush her father's ashes down the toilet. - July 5 2021 - Kiena, six months pregnant, is given a black eye by Wellings. She rang the police but before they arrive he tells her they ...

Perhaps a too-fast flow of drops from the moxifloxacin bottle was ... as efficiently as gatifloxacin and lost more of the drug. This would be consistent with a possible increased flow rate due ...

for its Abbreviated New Drug Application for Loteprednol Etabonate Ophthalmic Gel, 0.38%. Loteprednol Etabonate Ophthalmic Gel, 0.38% is a corticosteroid indicated for the treatment of post ...

Shojaei was instrumental in the clinical development and the eventual FDA approval of Xiidra®, the first product approved to treat both the signs and symptoms of dry eye disease (DED).